Immunicum AB News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.06.23	Mendus appoints NK cell pioneer Lewis Lanier to Scientific Advisory Board (GlobeNewswire)
19.06.23	Mendus receives ATMP certificate from European Medicines Agency supporting its lead pipeline program vididencel (GlobeNewswire)
15.06.23	Invitation to Mendus’ update on vididencel program as online and on-site events on June 27th, 2023 (GlobeNewswire)
12.06.23	Mendus presents comprehensive ADVANCE II immunomonitoring data at the EHA Annual Meeting 2023 (GlobeNewswire)
08.06.23	Mendus AB: Notice of Extraordinary General Meeting in Mendus AB (publ) (GlobeNewswire)
08.06.23	Mendus AB: Mendus announces a directed share issue and a fully secured rights issue of units totaling approximately SEK 317 million in financing (GlobeNewswire)
08.06.23	Mendus AB: Mendus and NorthX Biologics to enter into strategic cell therapy manufacturing alliance supported by new investor Flerie (GlobeNewswire)
25.05.23	Mendus to participate in upcoming conferences in June 2023 (GlobeNewswire)
17.05.23	Mendus secures third shareholder loan from Van Herk Investments (GlobeNewswire)
12.05.23	Mendus AB: Report from the Annual General Meeting of Mendus AB (publ) on 12 May 2023 (GlobeNewswire)
12.05.23	Mendus AB: Mendus AB (publ) Interim Report January – March 2023 (GlobeNewswire)
11.05.23	Mendus announces two upcoming presentations at the EHA2023 Hybrid Congress (GlobeNewswire)
28.04.23	Mendus AB: Change in number of shares and votes in Mendus AB (publ) (GlobeNewswire)
27.04.23	Mendus to participate in upcoming conferences in May 2023 (GlobeNewswire)
26.04.23	Mendus announces two upcoming presentations at the 2023 CIMT Annual Meeting (GlobeNewswire)
19.04.23	Mendus announces positive data from the ALISON trial in ovarian cancer presented at the AACR Annual Meeting 2023 (GlobeNewswire)
17.04.23	Mendus AB: Mendus (publ) publishes the Annual Report for 2022 and holds investor call on April 17th (GlobeNewswire)
11.04.23	Notice of Annual General Meeting in Mendus AB (publ) (GlobeNewswire)
06.04.23	Mendus redeems the outstanding convertible bonds from Negma Group (GlobeNewswire)
05.04.23	Mendus to participate in upcoming conferences in April 2023 and to hold investor call following Annual Report publication on April 17th (GlobeNewswire)
04.04.23	Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
04.04.23	Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
31.03.23	Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
31.03.23	Mendus AB: Change in number of shares and votes in Mendus AB (publ) (GlobeNewswire)
30.03.23	Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’267.50	3.22 %	K V
Sonova Hldg	313.00	2.96 %	K V
Novartis	93.83	2.48 %	K V
Geberit	525.80	1.78 %	K V
ABB	50.38	1.61 %	K V
UBS Group	28.40	0.92 %	K V
Lonza Grp	526.00	0.84 %	K V
Kuehne+Nagel Int	208.80	0.38 %	K V
Nestle	76.22	0.34 %	K V
Swisscom	506.00	0.10 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Immunicum AB

Aktien Top/Flop

Meistgelesene Nachrichten